Bacterial Bronchitis Caused by Streptococcus pneumoniae and Nontypable Haemophilus influenzae in Children The Impact of Vaccination
ΣυγγραφέαςPriftis, K. N.; Litt, D.; Manglani, S.; Anthracopoulos, M. B.; Thickett, K.; Tzanakaki, G.; Fenton, P.; Syrogiannopoulos, G. A.; Vogiatzi, A.; Douros, K.; Slack, M.; Everard, M. L.
Background: Protracted bacterial bronchitis is a major cause of persistent cough in childhood. The organisms most commonly isolated are nontypable Haemophilus infiuenzae and Streptococcus pneumoniae. There are no studies addressing typing of these organisms when recovered from the lower airways. Methods: Isolates of these two organisms (identified in BAL samples from children undergoing routine investigation of a chronic cough thought to be attributable to a protracted bacterial bronchitis) were subject to typing. Samples were collected in Sheffield, England, and Athens, Greece. The majority of the children from Sheffield had received pneumococcal-conjugate vaccines 7 or 13 (PCV-7 or PCV-13) conjugate vaccine but only a minority of Greek children had received PCV-7. Results: All 18 S pneumoniae isolates from Greek BAL samples are serotypes contained in PCV-13 while 10 are contained in PCV-7. In contrast, 28 of the 39 samples from Sheffield contained serotypes that are not included in PCV-13. All 26 of the nontypable H influenzae samples obtained in Sheffield produced distinct multilocus variable-number tandem repeat analysis profiles. There was a significant difference between children from Athens and Sheffield in the distribution of serotypes contained or not contained in the pneumococcal vaccine (P = .04). More specifically, immunization with pneumococcal vaccine was related with isolation of S pneumoniae serotypes not included in the vaccine (OR, 0.021; CI, 0.003-0.115; P < .001). Conclusions: The data suggest that both vaccine and nonvaccine S pneumoniae serotypes may play a role in protracted bacterial bronchitis and provide some hints that serotype replacement may occur in response to the introduction of conjugate vaccines. CHEST 2013; 143(1):152-157